Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Manuel Battegay and Marcel Stoeckle.
Manuel Battegay
Connection Strength
0.287
Marcel Stoeckle
  1. Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study. Swiss Med Wkly. 2021 08 02; 151:w20550.
    View in: PubMed
    Score: 0.060
  2. Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19. Drug Saf. 2021 02; 44(2):255-257.
    View in: PubMed
    Score: 0.057
  3. Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial. BMJ Open. 2020 11 12; 10(11):e040110.
    View in: PubMed
    Score: 0.057
  4. Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect. J Antimicrob Chemother. 2020 10 01; 75(10):3084-3086.
    View in: PubMed
    Score: 0.057
  5. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Antimicrob Agents Chemother. 2020 08 20; 64(9).
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.